Note 1 - Description of Business and Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2026

Notes Tables

Accounting Standards Update and Change in Accounting Principle [Table Text Block]

	Number of									Accumulated Other
	Shares of		Common		Additional		Accumulated			Comprehensive			Total Shareholders'
	Common Stock		Stock		Paid-in Capital		Deficit			Loss			Equity
Balance at December 31, 2023	$	7,748,922	$	774,893	$	22,964,490	$	(10,491,934	)	$	(2,916,372	)	$	10,331,077
Impact of Adoption of ASU 2018-12, net of income taxes		-		-		-		(1,124	)		2,114,541			2,113,417
Balance at January 1, 2024	$	7,748,922	$	774,893	$	22,964,490	$	(10,493,058	)	$	(801,831	)	$	12,444,494

				Impact to
				Accumulated Other
	Impact to			Comprehensive
	Accumulated Deficit			Income (Loss)
Long-Duration - Fixed Annuity	$	-		$	-
Long-Duration - Universal Life		-			-
Long-Duration - Individual Life		(1,424	)		2,677,633
Long-Duration - Critical Illness		1			(999	)
Total Impact of Adoption of ASU 2018-12, before Income Taxes		(1,423	)		2,676,634
Less: income taxes		299			(562,093	)
Total Impact of Adoption of ASU 2018-12, net of Income Taxes	$	(1,124	)	$	2,114,541

	Individual Life			Critical Illness			Total
Balance at December 31, 2023	$	1,702,286		$	11,632		$	1,713,918
Impact to retained earnings (accumulated deficit) from capping of net premium ratio at transition date		-			-			-
Impact of deferred profit liability		1			(1	)		-
Beginning balance at original discount rate		1,702,287			11,631			1,713,918
Impact of flooring		18,217			78			18,295
Effect of change in discount rate assumptions		(173,418	)		(822	)		(174,240	)
Balance at January 1, 2024	$	1,547,086		$	10,887		$	1,557,973

	Individual Life			Critical Illness			Total
Balance at December 31, 2023	$	35,351,428		$	12,501		$	35,363,929
Effect of change in discount rate assumptions		(2,878,888	)		(1,286	)		(2,880,174	)
Balance at January 1, 2024	$	32,472,540		$	11,215		$	32,483,755
Net liability for future policy benefits	$	30,925,454		$	328		$	30,925,782
Less: Reinsurance recoverable		69,160			(1,015	)		68,145
Net liability for future policy benefits, after reinsurance recoverable	$	30,856,294		$	1,343		$	30,857,637

	December 31, 2024
	Historical Accounting
Balance Sheet	Method			As Adjusted			Effect of Change
Assets
Reinsurance related assets	$	522,142		$	788,886		$	266,744
Deferred acquisition costs, net		3,908,636			4,402,995			494,359
Deferred tax asset, net of valuation allowance		3,747,111			2,862,157			(884,954	)
Total Assets	$	8,177,889		$	8,054,038		$	(123,851	)
Liabilities
Policyholder benefit reserves	$	39,898,138		$	36,444,940		$	(3,453,198	)
Deposit-type contracts		77,940,378			77,940,378			-
Total Liabilities	$	117,838,516		$	114,385,318		$	(3,453,198	)
Shareholders' Equity
Accumulated deficit	$	(10,020,956	)	$	(9,952,686	)	$	68,270
Accumulated other comprehensive (loss) income		(3,090,176	)		170,902			3,261,078
Total Shareholders' Equity	$	(13,111,132	)	$	(9,781,784	)	$	3,329,348

	March 31, 2025
	Historical Accounting
Balance Sheet	Method			As Adjusted			Effect of Change
Assets
Reinsurance related assets	$	870,616		$	1,208,387		$	337,771
Deferred acquisition costs, net		3,957,070			4,585,245			628,175
Deferred tax asset, net of valuation allowance		4,003,493			3,144,992			(858,501	)
Total Assets	$	8,831,179		$	8,938,624		$	107,445
Liabilities
Policyholder benefit reserves	$	41,499,062		$	38,488,961		$	(3,010,101	)
Deposit-type contracts		74,759,710			74,759,710			-
Total Liabilities	$	116,258,772		$	113,248,671		$	(3,010,101	)
Shareholders' Equity
Accumulated deficit	$	(11,392,901	)	$	(11,300,126	)	$	92,775
Accumulated other comprehensive (loss) income		(2,514,843	)		509,927			3,024,770
Total Shareholders' Equity	$	(13,907,744	)	$	(10,790,199	)	$	3,117,545

	Three Months Ended March 31, 2025
	Historical Accounting
	Method			As Adjusted			Effect of Change
Statement of Income
Premium income	$	4,419,593		$	4,419,593		$	-
Policy benefits		2,092,539			2,092,539			-
Increase in policyholder reserves		1,565,550			1,673,870			108,320
Amortization of deferred acquisition costs		307,263			167,924			(139,339	)
Deferred income tax benefit (expense)		222,833			216,319			(6,514	)
Net loss		(1,371,945	)		(1,347,440	)		24,505
Net loss per common share, basic and diluted	$	(0.18	)	$	(0.17	)	$	0.00
Statement of Comprehensive Income (Loss)
Net loss	$	(1,371,945	)	$	(1,347,440	)	$	24,505
Change in the effect of discount rate assumptions on the liability for future policy benefits, net of reinsurance, net of tax		-			(236,308	)		(236,308	)
Comprehensive loss	$	(796,612	)	$	(1,008,415	)	$	(211,803	)
Statement of Shareholders' Equity
Accumulated other comprehensive income (loss) balance at beginning of year	$	(3,090,176	)	$	170,902		$	3,261,078
Other comprehensive income		575,333			339,025			(236,308	)
Shareholders' equity balance at beginning of year		10,630,418			13,959,766			3,329,348
Net loss		(1,371,945	)		(1,347,440	)		24,505
Statement of Cash Flows
Cash flows from operating activities	$	2,253,158		$	2,253,158		$	-
Net loss		(1,371,945	)		(1,347,440	)		24,505
Deferred acquisition costs amortized		307,262			167,924			(139,338	)
Deferred income taxes		(256,382	)		(333,255	)		(76,873	)
Change in reinsurance related assets		(467,236	)		(419,501	)		47,735
Change in policy owner benefit reserves		1,600,924			1,744,897			143,973